Targeted gene panels use advanced sequencing technologies to analyze multiple genes at once. The process begins with the extraction of DNA from tumor samples, which is then sequenced to identify genetic alterations. Bioinformatics tools are used to interpret the data, identifying actionable mutations that can be targeted with specific therapies. This method is faster and more cost-effective compared to whole-genome sequencing.
